希斯蒂丁酸酶-铁灭酶交叉调节用于有效的肝细胞癌治疗
Yang Qin1, Xiaoli Ling1, Yunxian Li1
1Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, 421001, China.
这项研究引入了一种新型的非铁性铁治疗肝癌,通过使用通过前药物输送的miRNA抑制剂来调节Histidine酸酶 (LHPP) 的上升. 这种方法结合化疗和基因疗法来激活铁亡并增强瘤免疫性.
科学领域:
- 生物化学 生物化学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 传统化疗在瘤治疗方面面临着局限性.
- 通过非铁性方法诱导铁死提供了一个有希望的替代方案,以克服安全问题.
- 胺酸酶 (LHPP) 是肝细胞癌 (HCC) 的潜在治疗点,但其机制尚不清楚.
研究的目的:
- 为了研究上调LHPP表达对HCC中铁和瘤免疫性的影响.
- 探索LHPP介导的铁亡的机制及其治疗潜力.
- 开发一种结合化疗和基因疗法的新型药物输送系统,用于HCC治疗.
主要方法:
- 使用凝心素-油酸 (GOA) 前药物输送一个miRNA-363-5p抑制剂 (miR-363-5pi).
- 在GOA纳米颗粒中封装miRNA,以优化状料比率 (250:1).
- 纳米粒子尺寸 (147.1 nm) 和电位 (-21.5 mV) 的表征.
- 在携带Bel-7402瘤异端移植的裸体小鼠中评估瘤抑制率.
- 生物相容性和器官损伤的评估.
- 探索瘤免疫原激活潜力.
主要成果:
- 在GOA纳米粒子中有效封装miR-363-5pi.
- 升调LHPP抑制PI3K/Akt通路,引发非铁性铁亡.
- 在体内实现了88.2%的显著瘤抑制率.
- 证明了出色的生物相容性,没有显著的血液毒性或器官损伤.
- 确认了GOA/miR-363-5pi系统的瘤免疫原激活潜力.
结论:
- 这项研究阐明了LHPP在通过ferroptosis诱导治疗HCC中的机制.
- 它成功地整合了化疗和基因疗法,以激活铁亡并增强瘤免疫性.
- 这种方法为HCC治疗提供了一个新的治疗策略.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
